The clinical prognostic significance of myocardial performance index (MPI) in stable placental-mediated disease.

doi:10.5830/CVJA-2018-036

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

The clinical prognostic significance of myocardial performance index (MPI) in stable placental-mediated disease.

Cardiovascular journal of Africa - 1 Jan 2000

Bhorat I, Pillay M, Reddy T

Abstract excerpt

AIM: To determine whether a single elevated myocardial performance index (MPI) value in the third trimester of pregnancy is a marker for later adverse obstetric outcomes in stable placental-mediated disease, defined as well-controlled pre-eclampsia (PE) on a single agent and/or uncompensated intra-uterine growth restriction (IUGR). METHODS: Fifty-five foetuses whose mothers had stable placental-mediated disease,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gestational Age
Share to Echocardiography, Doppler
Share to Fetal Growth Retardation
Share to Fetal Heart

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Pre-Eclampsia

Share to Predictive Value of Tests

Share to Pregnancy Trimester, Third

Share to Ultrasonography, Prenatal

Source

Open in PubMed Open full text

Identifiers

PMID: 30152840
DOI: 10.5830/CVJA-2018-036
PMCID: PMC8962708

Genes

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.